 SOUTH SAN FRANCISCO, Calif., June 01, 2022 GLOBE NEWSWIRE -- CytomX Therapeutics, Inc. Nasdaq: CTMX, a leader in the field of conditionally activated oncology therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 2:00 p.m. ET. 